International Symposium on Atopic Dermatitis/8th Georg Rajka Symposium May 21st -23rd 2014
Abstract submission template
Please submit your abstract by 31st January 2014 using the following template and instructions. Abstracts to be
submitted by e-mail to: cebd@nottingham.ac.uk. In the subject heading of the e-mail, please include: ISAD
abstract + your surname (e.g. ISAD abstract Williams). Abstracts will be considered by the ISAD Scientific
Committee and you will be notified by the end of March 2014 regarding the outcome of your submission.
Instructions for authors:

Submission deadline 31st January 2014

Maximum of 400 words for the main body of the abstract (excluding title, authors and references)

You may include a maximum of 2 references

Do not include acknowledgements or disclaimers in the abstract

Include authors and affiliations (these will be removed prior to assessment)

Use the headings provided in the abstract box below where possible

If you wish to be considered for an oral presentation, please select which session

If using acronyms please write them out in full
Session:
Poster only (all categories Wed 21st –Fri 23rd May)
OR
x Oral or poster
If you would like your abstract to be considered for an oral presentation, please denote which session:
Causes of atopic dermatitis – genetics and environment (Oral presentations Wed 21st May)
Mechanisms of atopic dermatitis (Oral presentations Thurs 22nd May)
X Prevention of atopic dermatitis (Oral presentations Thurs 22nd May)
Treatment of atopic dermatitis (Oral presentations Fri 23rd May)
Title of abstract:
The SCIN (Skin Care Intervention in Nurses) Trial. A cross-sectional feasibility study in Wales (Stage
1).
Authors (please include full contact details for corresponding author and relevant affiliations for all
including conflicts of interest):
Mr Vaughan Parsons, Prof David Coggon, Prof Barry Cookson, Dr John English, Prof Dame Tina
Lavender, Prof Paul McCrone, Dr Ira Madan (CI), Ms Caroline Murphy, Ms Georgia Ntani, Dr Lesley
Rushton, Dr Julia Smedley, Prof Hywel Williams, Dr Alison Wright.
Main Abstract (maximum 400 words, please use the sub-headings below where possible):
Why are we doing this study?
To inform the implementation of a large-scale cluster randomised controlled trial in England. The
main objectives of the feasibility study are:
1. To assess better the numbers of eligible participants that can be expected in the main study and
the response rates that are likely to be obtained
2. To test the main study protocol and instruments, including the photographic method of assessing
the presence and severity of dermatitis (1,2)
3. To test the study intervention, a behavioural change programme (BCP)
4. To assess the baseline prevalence of hand dermatitis to refine power calculations for the main
study
5. To test the feasibility of recruitment of participants through the occupational health (OH) service.
What will we do?
Key Steps of Research Procedure:
1. All student nurses who are due to start their first clinical placement, and who had a history of
atopic disease or hand dermatitis and all intensive care unit (ICU) nurses at the study site will be
identified by the lead OH clinician and Head of ICU respectively and invited to participate.
2. Participants will complete a baseline questionnaire and have their hands photographed and
swabbed.
3. The student nurses will be offered the BCP and will be provided with a personal supplies of
emollient
4. Optimal equipment for hand cleansing and drying will be placed on ICU along with dispensers of
moisturising cream. ICU staff will be offered the BCP.
5. Two weeks after the BCP is offered, participants will be asked to complete a second
questionnaire exploring their beliefs regarding dermatitis prevention behaviours and their views
on the BCP.
6. The dermatologists will review any problems associated with the photographic method for
assessing the severity of dermatitis.
7. A purposive sample of participants and the lead OH clinician will be interviewed to seek
qualitative feedback on experiences and application of research tools and processes.
What do we hope to show
The main purpose of this presentation is to provide an overview of the SCIN trial feasibility study. It is
likely that the SCIN research team will be able to provide delegates with a draft summary of key
findings.
What does it mean?
We anticipate the findings from this study will enhance our knowledge and understanding of
research approaches that can be adopted by researchers to investigate hand dermatitis and
dermatitis-prevention in healthcare settings.
This project was funded by the National Institute for Health Research [Health
Technology Assessment] (project number 11/94/01)
References
1. Coenradds, P., Van Der Walle, H., Thestrup-Pedersen, k., Ruzicka, T., Dreno, B., De La Loge, C.,
Viala, M., Querner, S., Brown, T and Zultak, M (2005). Construction and validation of a
photographic guide for assessing severity of chronic hand dermatitis. The British journal of
dermatology, 152(2), pp. 296-301.